Jun-Hong Li1, Ning Wu2, Hong-Mei Yang3, Hong-Bing Tang1, Dong-Ping Bao1, Jun-Min Ji4. 1. Inspection Center, Changzhou Center for Disease Control and Prevention, No. 203, Taishan Road, The New North District, Changzhou, 213022, Jiangsu, People's Republic of China. 2. Department of Clinical Laboratory, The First Hospital of Hengyang, Hengyang, 421001, Hunan, People's Republic of China. 3. Department of Blood Quality Management, Changzhou Blood Center, Changzhou, 213004, Jiangsu, People's Republic of China. 4. Inspection Center, Changzhou Center for Disease Control and Prevention, No. 203, Taishan Road, The New North District, Changzhou, 213022, Jiangsu, People's Republic of China. jijunmin3313@163.com.
Abstract
AIMS: The aim of this study was to investigate the impact of the signal transducer and activator of transcription 3 (STAT3) gene and additional STAT3 gene-smoking interaction on Crohn's disease (CD) risk based on a Chinese population. METHODS: A total of 1012 participants (491 men, 521 women), were selected, including 502 CD patients and 510 normal controls. The mean age of all participants was 42.3 ± 11.2 years. Logistic regression model was used to examine the association between single nucleotide polymorphism (SNP) of STAT3 and CD risk; the odds ratio (OR) and 95 % confident interval (95 % CI) were calculated. Generalized multifactor dimensionality reduction was employed to analyze the interaction among several SNPs. RESULTS: Logistic analysis showed the significant association between genotypes of variants in two SNP and decreased CD risk, after covariates adjustment. The carriers of homozygous mutant of two SNP polymorphism revealed decreased CD risk than those with wild-type homozygotes; OR (95 % CI) was 0.75 (0.59-0.93) and 0.68 (0.57-0.91), respectively. There was a significant two-locus model (p = 0.0107) involving rs744166 and smoking, indicating a potential gene-environment interaction between rs744166 and smoking. Overall, the cross-validation consistency was 10/10, and the testing accuracy was 62.17 %, and never smokers with TC or CC genotype have the lowest CD risk, compared to smokers with TT genotype; OR (95 % CI) was 0.52 (0.31-0.82), after covariate adjustment. CONCLUSIONS: Our results support an important association of rs744166 and rs4796793 with decreased CD risk, and additional interaction between rs744166 and smoking.
AIMS: The aim of this study was to investigate the impact of the signal transducer and activator of transcription 3 (STAT3) gene and additional STAT3 gene-smoking interaction on Crohn's disease (CD) risk based on a Chinese population. METHODS: A total of 1012 participants (491 men, 521 women), were selected, including 502 CD patients and 510 normal controls. The mean age of all participants was 42.3 ± 11.2 years. Logistic regression model was used to examine the association between single nucleotide polymorphism (SNP) of STAT3 and CD risk; the odds ratio (OR) and 95 % confident interval (95 % CI) were calculated. Generalized multifactor dimensionality reduction was employed to analyze the interaction among several SNPs. RESULTS: Logistic analysis showed the significant association between genotypes of variants in two SNP and decreased CD risk, after covariates adjustment. The carriers of homozygous mutant of two SNP polymorphism revealed decreased CD risk than those with wild-type homozygotes; OR (95 % CI) was 0.75 (0.59-0.93) and 0.68 (0.57-0.91), respectively. There was a significant two-locus model (p = 0.0107) involving rs744166 and smoking, indicating a potential gene-environment interaction between rs744166 and smoking. Overall, the cross-validation consistency was 10/10, and the testing accuracy was 62.17 %, and never smokers with TC or CC genotype have the lowest CD risk, compared to smokers with TT genotype; OR (95 % CI) was 0.52 (0.31-0.82), after covariate adjustment. CONCLUSIONS: Our results support an important association of rs744166 and rs4796793 with decreased CD risk, and additional interaction between rs744166 and smoking.
Authors: Leslie M Higuchi; Hamed Khalili; Andrew T Chan; James M Richter; Athos Bousvaros; Charles S Fuchs Journal: Am J Gastroenterol Date: 2012-07-10 Impact factor: 10.864
Authors: Xiang-Yang Lou; Guo-Bo Chen; Lei Yan; Jennie Z Ma; Jun Zhu; Robert C Elston; Ming D Li Journal: Am J Hum Genet Date: 2007-04-25 Impact factor: 11.025
Authors: Andre Franke; Tobias Balschun; Tom H Karlsen; Jürgen Hedderich; Sandra May; Tim Lu; Dörthe Schuldt; Susanna Nikolaus; Philip Rosenstiel; Michael Krawczak; Stefan Schreiber Journal: Nat Genet Date: 2008-04-27 Impact factor: 38.330
Authors: Siew C Ng; Charles N Bernstein; Morten H Vatn; Peter Laszlo Lakatos; Edward V Loftus; Curt Tysk; Colm O'Morain; Bjorn Moum; Jean-Frédéric Colombel Journal: Gut Date: 2013-01-18 Impact factor: 23.059
Authors: M C Cénit; A Alcina; A Márquez; J L Mendoza; M Díaz-Rubio; V de las Heras; G Izquierdo; R Arroyo; O Fernández; E G de la Concha; F Matesanz; E Urcelay Journal: Genes Immun Date: 2010-03-04 Impact factor: 2.676
Authors: Jason S Stumhofer; Jonathan S Silver; Arian Laurence; Paige M Porrett; Tajie H Harris; Laurence A Turka; Matthias Ernst; Christiaan J M Saris; John J O'Shea; Christopher A Hunter Journal: Nat Immunol Date: 2007-11-11 Impact factor: 25.606